ACLX vs AKAM · rev $107.9M vs P/E 27, rev $2.17B
Arcellx Inc (ACLX) versus Akamai Technologies Inc (AKAM) — a side-by-side from cached financials, not a winner call.
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
ACLX currently screens at market cap $6.73B. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Not investment advice. Open the ACLX and AKAM stock pages for the full models.
Not investment advice.